Xerox’s Top Executives Hold Millions in XRX Equity—Should They Sell Before Stock Prices Drop?

Toner News Forums Toner News Main Forums Xerox’s Top Executives Hold Millions in XRX Equity—Should They Sell Before Stock Prices Drop?

Tonernews.com, January 26, 2026. USA
  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts

  • toner
    Keymaster

    Xerox Holdings Corporation’s top executives — Steven Bandrowczak (CEO), Colon Flor (Officer), and Jacques-Edouard Gueden (Chief Revenue Officer) — hold significant equity stakes in the company through Restricted Stock Units (RSUs). With Xerox’s stock currently trading just above $2.00, these executives may want to consider selling some of their shares soon, as the company faces the risk of its stock falling below $1.00, which could trigger delisting concerns.

    Steven Bandrowczak – CEO: $3.29 Million Stake at Risk

    Steven Bandrowczak holds an equity stake valued at $3.29 million, consisting of 453,167 shares worth about $993,444 and 1,052,549 RSUs potentially worth $2.3 million. However, with the stock price at risk of dipping below $1.00, he may want to sell some shares to lock in value before further declines.

    Colon Flor – Officer: Holdings Worth $456,339

    Colon Flor holds 15,793 shares worth around $34,619 and 192,561 RSUs, which could convert into approximately $421,720 if they vest. His total equity is worth $456,339. With Xerox’s stock price hovering around $2.19, Flor may want to sell some shares to avoid the risk of significant losses if the stock falls below $1.00.

    Jacques-Edouard Gueden – Chief Revenue Officer: $624,328 in Holdings

    Jacques-Edouard Gueden holds 73,653 shares, worth about $161,249, and 211,819 unvested RSUs, valued at approximately $463,079. In total, his equity is worth $624,328. However, if Xerox’s stock price drops below $1.00, the value of his holdings could be significantly impacted, and he may want to sell some shares to protect their value.

    Conclusion: Time to Act for Xerox Executives

    The combined value of Bandrowczak, Flor, and Gueden‘s equity stakes is approximately $4.37 million. However, with Xerox’s stock price at risk of falling below $1.00, these executives may want to sell some shares sooner to safeguard their compensation’s value before the price declines further. If the stock price drops significantly, their equity stakes could lose considerable value, highlighting the urgency of acting now.

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty, or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action based on the content on our site.